APOTHEEK CANDIDE JACOBS: what changed
APOTHEEK CANDIDE JACOBS
Largest movements
- Cash +€62,859
up €62,859 (+53.1%), from €118,320 to €181,179
mainly Net result for the year (+€88,669) and Trade debts (+€42,486)
- Stocks and contracts -€15,455
down €15,455 (-7.2%), from €214,670 to €199,215
- Receivables within one year +€11,361
up €11,361 (+10.4%), from €109,227 to €120,588
of which Other amounts receivable: +€8,292
- Trade debts +€42,486
up €42,486 (+30.5%), from €139,367 to €181,852
- Other debts +€16,422
up €16,422 (+7.7%), from €212,761 to €229,183
- Current portion of long-term debt -€9,456
down €9,456 (-100%), from €9,456 to €0
- Tax, wage and social debts +€9,410
up €9,410 (+80.2%), from €11,738 to €21,148
of which Remuneration and social security: +€8,695
- Staff costs +€20,541
up €20,541 (+17.9%), from €114,539 to €135,080
- Depreciation -€19,782
down €19,782 (-86.2%), from €22,946 to €3,164
- Gross operating margin +€12,735
up €12,735 (+5.7%), from €225,313 to €238,048
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €455,695 | €515,835 | +€60,140 | +13.2% |
| Fixed assets | 21/28 | €10,605 | €11,373 | +€768 | +7.2% |
| Intangible fixed assets | 21 | €265 | €174 | -€91 | -34.3% |
| Tangible fixed assets | 22/27 | €6,339 | €7,198 | +€859 | +13.6% |
| Plant, machinery and equipment | 23 | €2,907 | €4,445 | +€1,538 | +52.9% |
| Furniture and vehicles | 24 | €3,432 | €1,904 | -€1,528 | -44.5% |
| Other tangible fixed assets | 26 | €0 | €849 | +€849 | |
| Financial fixed assets | 28 | €4,000 | €4,000 | = | 0.0% |
| Current assets | 29/58 | €445,090 | €504,462 | +€59,372 | +13.3% |
| Stocks and contracts in progress | 3 | €214,670 | €199,215 | -€15,455 | -7.2% |
| Stocks | 30/36 | €214,670 | €199,215 | -€15,455 | -7.2% |
| Amounts receivable within one year | 40/41 | €109,227 | €120,588 | +€11,361 | +10.4% |
| Trade receivables | 40 | €99,778 | €102,847 | +€3,069 | +3.1% |
| Other amounts receivable | 41 | €9,449 | €17,741 | +€8,292 | +87.7% |
| Cash at bank and in hand | 54/58 | €118,320 | €181,179 | +€62,859 | +53.1% |
| Deferred charges and accrued income | 490/1 | €2,873 | €3,480 | +€607 | +21.1% |
| Total equity and liabilities | 10/49 | €455,695 | €515,835 | +€60,140 | +13.2% |
| Equity | 10/15 | €80,725 | €81,383 | +€658 | +0.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €62,125 | €62,783 | +€658 | +1.1% |
| Tax-exempt reserves | 132 | €28,893 | €28,893 | = | 0.0% |
| Distributable reserves | 133 | €33,232 | €33,890 | +€658 | +2.0% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €374,970 | €434,452 | +€59,482 | +15.9% |
| Amounts payable after more than one year | 17 | €0 | - | = | |
| Financial debts | 170/4 | €0 | - | = | |
| Amounts payable within one year | 42/48 | €373,322 | €432,184 | +€58,862 | +15.8% |
| Current portion of amounts payable after more than one year | 42 | €9,456 | €0 | -€9,456 | -100% |
| Trade debts | 44 | €139,367 | €181,852 | +€42,486 | +30.5% |
| Suppliers | 440/4 | €139,367 | €181,852 | +€42,486 | +30.5% |
| Taxes, remuneration and social security | 45 | €11,738 | €21,148 | +€9,410 | +80.2% |
| Taxes | 450/3 | €420 | €1,134 | +€714 | +170% |
| Remuneration and social security | 454/9 | €11,319 | €20,014 | +€8,695 | +76.8% |
| Other amounts payable | 47/48 | €212,761 | €229,183 | +€16,422 | +7.7% |
| Accrued charges and deferred income | 492/3 | €1,648 | €2,268 | +€620 | +37.6% |
| Remuneration, social security and pensions | 62 | €114,539 | €135,080 | +€20,541 | +17.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,946 | €3,164 | -€19,782 | -86.2% |
| Other operating charges | 640/8 | €1,150 | €226 | -€924 | -80.4% |
| Gross operating margin | 9900 | €225,313 | €238,048 | +€12,735 | +5.7% |
| Operating profit (loss) | 9901 | €86,679 | €99,579 | +€12,900 | +14.9% |
| Financial income | 75/76B | €261 | €251 | -€9 | -3.6% |
| Recurring financial income | 75 | €261 | €251 | -€9 | -3.6% |
| Financial charges | 65/66B | €7,943 | €8,727 | +€784 | +9.9% |
| Recurring financial charges | 65 | €7,943 | €8,727 | +€784 | +9.9% |
| Profit (loss) for the period before taxes | 9903 | €78,997 | €91,103 | +€12,107 | +15.3% |
| Income taxes | 67/77 | €1,489 | €2,434 | +€945 | +63.5% |
| Profit (loss) for the period | 9904 | €77,508 | €88,669 | +€11,161 | +14.4% |
| Profit (loss) for the period to be appropriated | 9905 | €77,508 | €88,669 | +€11,161 | +14.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.